AROA BIOSURGERY LIMITED — Director's Dealing 2023

Mar 30, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aroa Biosurgery Limited ARBN 638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Philip McCaw
Date of last notice	12 April 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Direct or indirect interest		Direct & Indirect	Direct & Indirect	Direct & Indirect	Direct & Indirect
	Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest.		Phil McCaw <McSyth Capital InvestmentA/C> (Beneficiary)Phillip John McCaw & Anne ElizabethForsyth <McSyth Charitable Found A/C>(Beneficiary)
			(Bene	ficiary)
	Date of change		31 Ma	rch 2023
	No. of securities held prior to change		IndireMcSyt	cth Capital Investm	ent Trust of whic
			is a tr	ustee and benefic	iaryOrdinary Share
			19,518192	5,326 Fully Paid5 Fully Paid
					Ordinary Shares
			,	uy y
	Class		OptionFebru	s exercisable at $1.083 expirinary 2028		g 29
	Number acquired		172,6	20
	Number disposed		-

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation		Nil
No. of securities held after change		Direct172,620 Options exercisable at $1.083expiring 29 February 2028Indirect
		McSyth Capital Investment Trust of whichhe is a trustee and beneficiary19,515,326 Fully Paid Ordinary Share81,925 Fully Paid Ordinary Shares, tobe held in escrow until 13 April202381,925Options exercisable at $0.75expiring 23 July 2025McSyth Charitable A/C of which he is atrustee and beneficiary153,903Fully Paid Ordinary Share
Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participationin buy-back		Issued on 31 March 2023 pursuant toshareholderapprovalreceivedattheAnnual General Meeting held on 10 August2022

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	-
Nature of interest	-
Name of registered holder(if issued securities)	-
Date of change	-
No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to which theinterest has changed	-
Interest acquired	-
Interest disposed	-
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation	-
Interest after change	-

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period	Part 3 –+Closed period
Were the interests in the securitiecontracts detailed above traded dur
	Were the interests in the securitiecontracts detailed above traded dur	s orn a	No
	+closedperiodwherepriorwclearance was required?	gritten
	If so, was prior written clearance proto allow the trade to proceed durin	videdthis	N/A
	period?
	If prior written clearance was provide	d on	N/A
what date was this provided?	what date was this provided?	,

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3